vorasidenib
servier
['vorasidenib', 'indigo']
don t miss us #asco23 at 1:00! s timothy cloughesy, md research will be presented in a plenary session titled indigo: phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an idh1/2 mutation. hall b1. 
We are accelerating discoveries to prevent and cure cancer.